POMDOCTOR Net Income From Continuing Ops from 2010 to 2026
| POM Stock | 0.24 0.01 4.35% |
Net Loss | First Reported 2010-12-31 | Previous Quarter -43 M | Current Value -45.1 M | Quarterly Volatility 28.5 M |
Check POMDOCTOR LIMITED financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among POMDOCTOR LIMITED's main balance sheet or income statement drivers, such as Depreciation And Amortization of 147 K, Interest Expense of 14.2 M or Total Revenue of 374.2 M, as well as many indicators such as Price To Sales Ratio of 13.42, Dividend Yield of 0.0 or Days Sales Outstanding of 19.31. POMDOCTOR financial statements analysis is a perfect complement when working with POMDOCTOR LIMITED Valuation or Volatility modules.
POMDOCTOR | Net Income From Continuing Ops | Build AI portfolio with POMDOCTOR Stock |
Evaluating POMDOCTOR LIMITED's Net Income From Continuing Ops across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into POMDOCTOR LIMITED American's fundamental strength.
Latest POMDOCTOR LIMITED's Net Income From Continuing Ops Growth Pattern
Below is the plot of the Net Income From Continuing Ops of POMDOCTOR LIMITED American over the last few years. It is POMDOCTOR LIMITED's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in POMDOCTOR LIMITED's overall financial position and show how it may be relating to other accounts over time.
| Net Income From Continuing Ops | 10 Years Trend |
|
Net Income From Continuing Ops |
| Timeline |
POMDOCTOR Net Income From Continuing Ops Regression Statistics
| Arithmetic Mean | (78,612,826) | |
| Coefficient Of Variation | (36.24) | |
| Mean Deviation | 24,803,322 | |
| Median | (96,181,846) | |
| Standard Deviation | 28,491,951 | |
| Sample Variance | 811.8T | |
| Range | 76.3M | |
| R-Value | 0.75 | |
| Mean Square Error | 373.8T | |
| R-Squared | 0.57 | |
| Significance | 0.0005 | |
| Slope | 4,253,543 | |
| Total Sum of Squares | 12988.7T |
POMDOCTOR Net Income From Continuing Ops History
About POMDOCTOR LIMITED Financial Statements
POMDOCTOR LIMITED investors utilize fundamental indicators, such as Net Income From Continuing Ops, to predict how POMDOCTOR Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Loss | -43 M | -45.1 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out the analysis of POMDOCTOR LIMITED Correlation against competitors. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Will Pharmaceutical Retailers sector continue expanding? Could POMDOCTOR diversify its offerings? Factors like these will boost the valuation of POMDOCTOR LIMITED. Anticipated expansion of POMDOCTOR directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every POMDOCTOR LIMITED data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Investors evaluate POMDOCTOR LIMITED using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating POMDOCTOR LIMITED's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause POMDOCTOR LIMITED's market price to deviate significantly from intrinsic value.
It's important to distinguish between POMDOCTOR LIMITED's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding POMDOCTOR LIMITED should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, POMDOCTOR LIMITED's market price signifies the transaction level at which participants voluntarily complete trades.